Ikaros Proteins in Tumor: Current Perspectives and New Developments.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ikaros is a Krüppel family zinc finger transcription factor crucial for lymphopoiesis and tumorigenesis.
• It directly influences tumor suppressor genes and oncogenes, affecting cancer cell survival and proliferation.
• Extensive research has elucidated the link between Ikaros and various cancers.

Purpose of the Study:

• To review the multifaceted role of Ikaros in cancer development.
• To examine the mechanisms underlying therapeutic resistance to Ikaros-targeted treatments.
• To summarize the progress and future potential of Ikaros-targeted cancer therapies.

Main Methods:

• Literature review of studies on Ikaros function in tumorigenesis.
• Analysis of pre-clinical and clinical trial data for Ikaros-targeted therapies.
• Investigation into the molecular mechanisms of drug resistance.

Main Results:

• Ikaros plays a significant role in initiating and suppressing key cancer-related genes.
• Targeting Ikaros has demonstrated therapeutic efficacy in pre-clinical and clinical settings.
• Drug resistance to Ikaros-targeted agents is a growing concern.

Conclusions:

• Ikaros is a critical regulator in cancer biology, offering a viable therapeutic target.
• Understanding and overcoming drug resistance mechanisms are essential for effective Ikaros-targeted cancer therapy.
• Further research into associated therapies holds potential for advancing cancer treatment strategies.